简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-12-02 13:16 ANANDA Scientific Announces FDA Approval of the IND for a Clinical Trial exploring treatment of Social Anxiety Disorder (SAD)
2022-12-02 10:03 New Prospective Study Finds That Masimo SpHb® Noninvasive and Continuous Hemoglobin Monitoring Can Help Provide Effective Blood Management in Patients Undergoing Major Surgery
2022-12-02 09:52 Deadline for Aster Guardians Global Nursing Award 2023 worth US $250,000 extended until 12th December
2022-12-01 14:07 AGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH
2022-12-01 10:01 ViiV Healthcare Unveils a New Global Study Revealing Three Quarters of People Believe There Are Still Negative Perceptions When It Comes to People Living With HIV
2022-11-30 18:47 Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership
2022-11-30 14:32 Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug
2022-11-30 09:52 LevitasBio Strengthens its C-Suite
2022-11-29 19:05 Exscientia Receives First CTA Approval to Initiate IGNITE-AI, a Phase 1/2 Trial of EXS-21546 in Patients with Advanced Solid Tumours
2022-11-28 14:39 Ferinject® approved in Chinafor the treatment of iron deficiency in adult patients
2022-11-28 14:37 Biocytogen Enters into Antibody Agreement with ADC Therapeutics
2022-11-25 14:42 Iron Deficiency Day 2022: CSL Vifor calls to take iron seriously
2022-11-24 09:51 Takeda’s Biologics License Application (BLA) for Dengue Vaccine Candidate (TAK-003) Granted Priority Review by U.S. Food and Drug Administration
2022-11-23 14:00 Pacific Prime releases its Global Employee Benefits Trends Report 2022
2022-11-22 15:38 Philip Morris International Launches New BONDS by IQOS Smoke-Free Device to Accelerate the Achievement of a Smoke-Free Future
2022-11-22 09:18 Merck Aims to Double R&D Productivity in Oncology, Neurology and Immunology to Deliver More Medicines to Patients Faster
2022-11-21 16:36 DentalMonitoring Files Patent Infringement Lawsuit Asserting Three Patents Against Align Technology
2022-11-21 14:59 Monrol and FutureChem Announced a Clinical Supply Partnership
2022-11-21 09:35 Phase 3 Trial of ICLUSIG® (ponatinib) Met Primary Endpoint in Newly-Diagnosed Ph+ ALL, a Setting with No Targeted Treatments Approved in the US
2022-11-18 22:23 DEXLEVO at AMWC JAPAN: a Successful Debut

Business Wire Weibo

Press Releases

Latest Releases